Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00809224 · ClinicalTrials.gov registry record
Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 92
- Enrollment target
NCT00809224: Completed study, sponsored by University of Michigan.
NCT00809224 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 92 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00809224 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
Study Summary
The purpose of this study is to track areas of the brain, via functional magnetic resonance imaging (fMRI), that retain structural and functional integrity throughout the lifespan of people with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-05 |
What the finished NCT00809224 record still lists
NCT00809224 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 92 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00809224 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00809224 about?
NCT00809224 is a clinical study titled "Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)". The purpose of this study is to track areas of the brain, via functional magnetic resonance imaging (fMRI), that retain structural and functional integrity throughout the lifespan of people with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
What is the current status of trial NCT00809224?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2008-05. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT00809224?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia